Search


As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018
Daphne Koller describes the platform insitro has been building since it was founded in 2018.
Feb 21, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.